Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-03-04 Dethlefs Sven EVP Global Marketing&Portfolio Grant or award · Restricted Share Units +41,791 41,791
2019-03-04 de Notaristefani Carlo Executive VP Global Operations Grant or award · Restricted Share Units +74,626 74,626
2019-03-04 Daniell Richard Exec. VP, European Commercial Grant or award · Restricted Share Units +47,761 47,761
2019-03-04 Codner Iris Beck EVP Global Brand&Communication Grant or award · Restricted Share Units +26,865 26,865
2019-03-04 Nazzi Gianfranco EVP, Growth Markets Commercial Sale −512 $16.88 $9K 7,892.36
2019-03-04 O'Grady Brendan P. EVP, North America Commercial Sale −1,166 $16.88 $20K 1,388.49
2019-03-04 McClellan Michael James EVP, Chief Financial Officer Sale −363 $16.88 $6K 12,330.27
2019-03-04 Griffin Deborah A Chief Accounting Officer Sale −2,941 $16.88 $50K 1,166
2019-03-04 Griffin Deborah A Chief Accounting Officer Sale −1,166 $16.88 $20K 0
2019-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +1,165 16,502.51
2019-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Sale −409 $16.88 $7K 16,093.51
2019-03-04 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −1,165 0
2019-03-04 Dethlefs Sven EVP Global Marketing&Portfolio Sale −606 $16.88 $10K 8,057.7
2019-03-04 Daniell Richard Exec. VP, European Commercial Sale −2,098 $16.88 $35K 0
2019-03-03 Nazzi Gianfranco EVP, Growth Markets Commercial Option exercise +1,399 8,404.36
2019-03-03 Nazzi Gianfranco EVP, Growth Markets Commercial Option exercise · Restricted Share Units −1,399 2,799
2019-03-03 O'Grady Brendan P. EVP, North America Commercial Option exercise +1,166 2,554.49
2019-03-03 O'Grady Brendan P. EVP, North America Commercial Option exercise · Restricted Share Units −1,166 2,332
2019-03-03 McClellan Michael James EVP, Chief Financial Officer Option exercise +1,049 12,693.27
2019-03-03 McClellan Michael James EVP, Chief Financial Officer Option exercise · Restricted Share Units −1,049 2,099

Page 67 of 76 · 1,517 trades